drugset

drugset / Trial / NCT03864445

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients

NCT03864445 ↗

Phase 2 Completed 47 enrolled Kyowa Kirin, Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the effect and safety of KHK7791 in combination with phosphate binders to treat Hyperphosphatemia in ptatients on HD.

Timeline

Start: 2019-04-29
Primary completion: 2019-12-03
Completion: 2019-12-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tenapanor	Small molecule	—	Oral

Indications